Title: FDA Prehistory
1FDA Prehistory
- 1862, President Lincoln appointed first director
of Department of Agriculture - 1883 Request for petition to pass laws
prohibiting adulteration misbranding of foods
and drugs. - For serious drinking, the drugstore was the place
to go. Lydia E. Pinkham's Vegetable Compound, a
popular nostrum for women, was depending on the
formula, 15 to 20 percent alcohol (VU).
2Advertising Cards
- A common method for medicine-makers to hawk their
products was to provide druggists with
postcard-sized advertisements with a picture on
one side and a description of the glories of the
product on the other. - Ayer's Sarsaparilla
- Dr. Morse's Indian Root Pills
- Hires' Root Beer
- Lydia E. Pinkham's Vegetable Compound
- Pond's Extract
- Rumford Yeast Powder
- Wells, Richardson, Co.'s Lactated Food
3The Jungle, Upton Sinclair, 1906
- with the hot weather there descended upon
Packingtown a veritable Egyptian plague of flies
there could be no describing this--the houses
would be black with them. There was no escaping
you might provide all your doors and windows with
screens, but their buzzing outside would be like
the swarming of bees, and whenever you opened the
door they would rush in as if a storm of wind
were driving them. (Chapter 10)
4FDA History
- 1906 FDA formed, banned interstate commerce in
adulterated misbranded food, drink, and drugs - 1938 107 deaths of (primarily) children due to
ingestion of Elixir of Sulfanilamide, a toxic
combination of diethylene glycol and sulfa. - gt1938 Federal Food, Drug and Cosmetic Act
5FDA Act 1938
- requiring that new drugs be shown to be safe
before marketing. - extending FDAs control to cosmetics and
therapeutic devices. - authorizing factory inspections and standards of
identity for food staples. - eliminating a requirement to prove intent to
defraud in drug misbranding cases. - adding court injunctions to the previous
penalties of seizures and prosecutions
6Drug Testing Guidelines
- Chemical Composition
- Acute toxicity studies in two species
- Chronic toxicity studies with different doses in
different species - Observation of animals
- Pathological examination of animals
- Studies on the absorption and elimination of the
chemical - Study of interactions
- Knowledge of idiosyncrasies and untoward
reactions
7http//www.mtn.org/quack/
Get Rid of the Spectacle Nuisance Regain Your
Eye Freedom SIMPLY-SATISFACTORILY-SAFELY The
Natural Eyesight System Tells You How No
Doctoring-No Drugs-No DangerNothing to Wear and
Nothing to Fear
8(No Transcript)
9FDA History Continued
- 1962 sale/use of thalidomide banned in U.S. based
upon thousands of birth defects, primarily in
Europe South America amendment for efficacy
safety - 1969 hearings re injuries (10,000) deaths
(731) in a 10 year period heart valves,
pacemakers, IUDs, (Nader)
10FDA History Continued
- gt 1976 Medical Device Amendments newgt review,
oldgtgrandfathered, new equivalentgtgrandfathered
- gt1978 Good Manufacturing Practices
- gt1984 Medical Device Reporting
- gt1988 Device Recall/Rebuild
- gt1990 Safe Medical Devices
11FDA History Continued
- gt1992 Medical Device Amendments tracking,
surveillance, reporting, refund, .. - gt1997 Modernization Act public health is a
responsibility shared by the entire health care
community. The law directs the agency to carry
out its mission in consultations and cooperation
with all FDA stakeholders, including consumer and
patient groups, the regulated industry, health
care professionals, and FDAs regulatory
counterparts abroad
12Labeling
- FDA (also) regulates the labeling of products
under its jurisdiction. This information, which
must be rigorously truthful, well documented, and
not misleading, plays a major role in protecting
consumers and the public health. The
FDA-regulated food label is helping shoppers eat
a healthy diet the labeling of drugs and medical
devices gives prescribers and patients reliable
guidance about the safety and effectiveness of
health care products.
13Recent TV Ad (October 2001)
- (several photos of couples, )
- 3 bottles of male virility compounds!
- Free three month supply, 3 bottles!
- Simply pay 8.50 shipping and handling charges
for each bottle! - No health claims are made for these pills in
accordance with FDA regulations.
14- A medical device is"an instrument, apparatus,
implement, machine, contrivance, implant, in
vitro reagent, or other similar or related
article, including a component part, or accessory
which is - - recognized in the official National
Formulary, or the United States Pharmacopoeia, or
any supplement to them, -
- intended for use in the diagnosis of disease or
other conditions, or in the cure, mitigation,
treatment, or prevention of disease, in man or
other animals, or - intended to affect the structure or any function
of the body of man or other animals, and which
does not achieve any of it's primary intended
purposes through chemical action within or on the
body of man or other animals and which is not
dependent upon being metabolized for the
achievement of any of its primary intended
purposes." - FDA Definition
15Is My Device a Medical Device?
- http//www.fda.gov/cdrh/devadvice/11.htmlstart
- http//www.fda.gov/cdrh/devadvice/313.html
- http//www.fda.gov/cdrh/devadvice/3132.htmlclass_
1 - http//www.fda.gov/cdrh/devadvice/3132.htmlclass2
- http//www.fda.gov/cdrh/devadvice/3132.htmlclass2
- http//www.fda.gov/cdrh/devadvice/3131.htmlprocee
d
16Special Terms
- 510k Premarket notification
- IDE investigational device exemption
- PMAA premarket approval application
- GLP good laboratory practices
- GMP good manufacturing practices
- Design Control
- IRB Institutional review board
17Class 1
- Not life sustaining
- No risk
- No standards
- 510k (some) gt registration gt listing gt GMP
(some) gt Record keeping - Tongue depressors, stethoscopes, screwdrivers,
18Class 2
- Not life sustaining, but must meet
control/performance standards - 510k gt IDE gt PMAA gt Registration gt Record
keeping - Sphygmanometer, powered wheelchairs, drapes,
infusion pumps
19Class 3
- Life sustaining
- 510k gt IDE gt data!!! gt PMAA gt Registration
gt Record Keeping - Data techniques must include failure mode
analysis, animal test, toxicology studies, human
trials (IRB), PDP (product development protocol.)
20FDA approval?
- One or more years
- Now you will be monitored
21Registration
- (All US (foreign optional)) (manufacturer or
preparer or processor or propagator of device)
must register yearly with FDA get a device
registration . (30 days change)
22Listing
- All manufacturers must list w FDA all devices
they market (q 6 mo.) - All manufacturers must supply FDA with all
labeling advance copy of new labeling.
23Registration Listing
- traceability recallability
- FDA may force recall, fines, reparations, repair,
- FDA may inspect devices, records, labeling,
documentation, licenses, laboratories, premises,
etc at virtually any time. - FDA requires reporting of adverse events (MAUDE
system.)
24Software
- If part of a device, generally must meet same
minimum standards as the device. - If standalone (say drug calculator) same general
levels I no risk, II some, esp. if in
radiation therapy machines, III life sustaining - 8-20 of all deaths are software related.
25Drugs
- FDA has even more say here.
- All drugs must be tested on at least 2 properly
chosen animal models (thalidomide). (Generally do
test tube toxicity test first, then animals.) - Testing on humans must go through three or more
stages under IRB control. Testing must stop if
there is any untoward event. - Powers fine, recall, inspect, etc.
26Animals?
- Chimpanzees, cats, dogs, mice/rats, primates,
rabbits, pigs, sheep, ferrets, woodchuck,
armadillo, guinea pigs, lobsters, chinchillas,
electric eels, opossums, angler fish, axolotl,
slugs, pigeons, shark, zebra fish, tropical fish,
trout, goldfish, C elegan, fruit fly, etc.
27Drug testing in Humans
- Under IRB approval (Informed consent)
- Phase 1 small cohort, 20-80 people, look for
major problems, safety, tolerance, dose limiting
toxicities, mode of entry, dose range - Phase 2 100 - 300, look for dosing concerns,
look for minor problems, efficacy, safety - Phase 3 1000-3000 develop and prove statistics
on efficacy, safety, tolerance, possible other
uses.
28FDA Approval?
- Screen 5000 compounds gt 5 trials gt 1 drug.
- Blind/Double blind studies
- High cost of development (360M), giving rise to
mathematical modeling simulation - Penalties! 100M fine Abbott Labs Q/A.
29http//www.apexbioscience.com/products.htm
For more detailed information on PHP, click
here) Indications Nitric
Oxide-induced shock Other proprietary
applications Status Established
patent position Proved NO scavenger
concept in sheep, dog, pig, and mouse
models Completed Phase 1 safety study
and initial Phase 1/2 patient trial for
NO-induced shock Completed continuous
infusion and dose escalation (Phase 2) clinical
trial Randomized, controlled Phase 3
trial to commence in 2001